News

Epicentre is launching a prospective cohort study in the Békourou health district to evaluate the in vivo effectiveness of the sulfadoxine-pyrimethami...

Session by session, discover the key findings from Epicentre’s latest studies, as well as – to mark the organisation’s 40th anniversary – the achievem...

As the Ebola disease outbreak, caused by the Bundibugyo virus, continues to spread in the Democratic Republic of Congo (DRC), Médecins Sans Frontières...

On May 15, the Democratic Republic of the Congo (DRC) declared its 17th Ebola virus disease outbreak, caused by the Bundibugyo virus, for which there ...

Despite its proven effectiveness, hydroxyurea remains difficult to access and underused in sub-Saharan Africa. Two studies conducted by Epicentre and ...

On May 15, 2026, the Democratic Republic of Congo's Ministry of Health officially declared an Ebola disease outbreak in the northeast of the country, ...

In Pakistan, Epicentre is conducting a study to better understand how new, all oral, shorter treatments for multidrug-resistant/rifampicin‑resistant t...

The AMoCo* study continues to highlight persistent challenges related to abortion care and complications in fragile and conflict-affected settings. Co...

With cholera epidemics on the rise and global vaccine stocks remaining under pressure, in 2024 the WHO prequalified a new oral cholera vaccine, Euvich...

At the World Conference on Lung Health held from November 18 to 21, 2025, in Copenhagen, Médecins Sans Frontières (MSF) and Epicentre have revealed th...